Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

In a latest study, it was found that higher consumption of ultra-processed food like breakfast cereals, ready meals, packaged bread and fizzy drinks might increase the risk of cancer. 

World Cancer Day: World Cancer Day: Study says breakfast cereals, fizzy drinks might increase risk of cancer

World Cancer Day 2023: Study says breakfast cereals, fizzy drinks might increase risk of cancer

In a latest study, it was found that higher consumption of ultra-processed food like breakfast cereals, ready meals, packaged bread and fizzy drinks might increase the risk of cancer.&nbsp;

According to the latest study done by the UK-based Imperial School of Public Health, it was found that higher consumption of ultra-processed food like breakfast cereals, ready meals, packaged bread and fizzy drinks might increase the risk of cancer.&nbsp;
In the study, it was mentioned that when there is a 10% increase in ultra-processed food consumption in a person's diet, there is a 6% increase in the mortality by cancer. Other than this, there is also a 16% increase in chances of breast cancer and a 30% increase in chances of ovarian cancer.&nbsp;
Senior author for the study also mentioned that this study added to the growing evidence that ultra-processed foods are likely to negatively impact our health including risk of cancer.&nbsp;
Also Read: <a href="https://www.editorji.com/lifestyle-news/health/world-cancer-day-2023-know-all-about-this-year-s-theme-1675309890648">World Cancer Day 2023: Know all about this year's theme</a>

In what could be a major breakthrough in curing cancer in humans, an experimental cancer-killing drug has been administered to the first human test subject ever.The of the trial is to find if the drug which has been tentatively named CF33-hNIS is safe for use in humans, and effective in killing off cancerous tumours. 
The drug is a genetically engineered virus that targets and kills cancer-causing cells and tumours. The name of the drug candidate is Vaxinia. 
CF33-hNIS is an "oncolytic virus" which was genetically modified to target, infect, and kill cancer cells while leaving healthy cells untouched. 
CF33-hNIS is classified as a "chimeric vaccinia poxvirus" and it was developed by Professor Yuman Fong, Chairman of the Sangiacomo Family in Surgical Oncology at the City of Hope hospital in the United States of America. 
Oncolytic viruses, by design, target and selectively kill tumour cells, while simultaneously stimulating the immune system to act against cancerous tissue. 

First human trial of cancer-killing drug conducted: all you need to know

The drug&nbsp;is a genetically engineered virus that targets and kills cancer-causing cells and tumours.

In what could be a major breakthrough in curing cancer in humans, an experimental cancer-killing drug has been administered to the first human test subject ever. The of the trial is to find if the&nbsp;drug which has been tentatively named CF33-hNIS&nbsp;is safe for use in humans, and effective in killing off cancerous tumours.&nbsp;
The drug&nbsp;is a genetically engineered virus that targets and kills cancer-causing cells and tumours. The name of the drug candidate is Vaxinia.&nbsp;
CF33-hNIS is an "oncolytic virus" which was genetically modified to target, infect, and kill cancer cells while leaving healthy cells untouched.&nbsp;
CF33-hNIS is classified as a "chimeric vaccinia poxvirus" and it was developed by Professor Yuman Fong, Chairman of the Sangiacomo Family in Surgical Oncology at the City of Hope hospital in the United States of America.&nbsp;
Also watch:&nbsp;<a href="https://www.editorji.com/world-news/did-monkeypox-spread-by-sex-at-2-raves-in-europe-who-expert-answers-1653313537234" target="_blank">Did Monkeypox spread by sex at 2 raves in Europe? WHO expert answers</a>
Oncolytic viruses, by design, target and selectively kill tumour cells, while simultaneously stimulating the immune system to act against cancerous tissue.&nbsp;

Australia will be the first country to eliminate cervical cancer which could be as soon as within the next 20 years. This is according to a study conducted by researchers at the Cancer Council New South Wales, The country's screening programs and National vaccinations are the reason for this medical achievement. By 2022, the cancer maybe in the "rare" category in Australia and researchers are hopeful that the incidence of the disease will decrease if the screening for Human Papilloma virus (HPV) continues. Australia aims to set an example for the rest of the world.

cancer research

Categories